Tempest Therapeutics, Inc. (TPST) has 1 SEC Form 4 insider filings on record in the last 90 days. That includes 1 insider purchase totalling $500K. Most recent filing: June 23, 2026.
| Date | Insider | Value | Shares | Stake | Pre-planned | Links |
|---|---|---|---|---|---|---|
| June 23, 2026 filed March 24, 2026 | Angel Matthew CEO and President | +$500,001 | 694,446 | New | No | |
|
|
||||||
Form 4 is the filing company officers, directors and 10% shareholders must submit to the SEC within two business days of trading their own company's stock. Open-market purchases generally carry more signal than sales, which are often scheduled in advance. More on how this works.
Real-time Telegram alerts the moment a Form 4 is filed. Filings shown here are delayed by 72 hours.
Start free